1. Home
  2. NRP vs AGIO Comparison

NRP vs AGIO Comparison

Compare NRP & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRP
  • AGIO
  • Stock Information
  • Founded
  • NRP 2002
  • AGIO 2007
  • Country
  • NRP United States
  • AGIO United States
  • Employees
  • NRP N/A
  • AGIO N/A
  • Industry
  • NRP Coal Mining
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NRP Energy
  • AGIO Health Care
  • Exchange
  • NRP Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • NRP 1.3B
  • AGIO 1.4B
  • IPO Year
  • NRP N/A
  • AGIO 2013
  • Fundamental
  • Price
  • NRP $103.51
  • AGIO $38.80
  • Analyst Decision
  • NRP
  • AGIO Buy
  • Analyst Count
  • NRP 0
  • AGIO 6
  • Target Price
  • NRP N/A
  • AGIO $57.40
  • AVG Volume (30 Days)
  • NRP 18.6K
  • AGIO 975.5K
  • Earning Date
  • NRP 08-06-2025
  • AGIO 07-31-2025
  • Dividend Yield
  • NRP 2.90%
  • AGIO N/A
  • EPS Growth
  • NRP N/A
  • AGIO N/A
  • EPS
  • NRP 10.64
  • AGIO 11.13
  • Revenue
  • NRP $219,503,000.00
  • AGIO $40,875,000.00
  • Revenue This Year
  • NRP N/A
  • AGIO $18.94
  • Revenue Next Year
  • NRP N/A
  • AGIO $201.70
  • P/E Ratio
  • NRP $9.52
  • AGIO $3.43
  • Revenue Growth
  • NRP N/A
  • AGIO 30.57
  • 52 Week Low
  • NRP $81.74
  • AGIO $23.42
  • 52 Week High
  • NRP $113.04
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • NRP 56.16
  • AGIO 58.69
  • Support Level
  • NRP $101.27
  • AGIO $34.71
  • Resistance Level
  • NRP $103.95
  • AGIO $37.73
  • Average True Range (ATR)
  • NRP 2.46
  • AGIO 1.50
  • MACD
  • NRP -0.31
  • AGIO 0.15
  • Stochastic Oscillator
  • NRP 58.42
  • AGIO 82.21

About NRP Natural Resource Partners LP Limited Partnership

Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. the majority of the revenue is generated from the Mineral Rights segment. Geographically, the business activity of the group functions through the United States.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: